These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9730152)

  • 41. [A case of advanced gastric cancer responding to combination chemotherapy with low-dose 5-FU plus CDDP].
    Ishio T; Kohnoe S; Endo K; Yamamoto M; Ikeda Y; Toh Y; Baba H; Okamura T; Kawamoto K
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1627-30. PubMed ID: 12355950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biweekly low-dose cisplatin and 5-fluorouracil combination chemotherapy for advanced gastrointestinal carcinoma].
    Kamata T; Morita A; Nakamoto A; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):859-64. PubMed ID: 10897212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical effects of postoperative immunochemotherapy with a combination of 5-FU, CDDP and lentinan for stage IVb gastric carcinoma and long-term pharmacokinetic studies on CDDP and 5-FU].
    Mio H; Terabe K
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):337-42. PubMed ID: 9051137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
    Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
    Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose all-trans retinoic acid enhances cytotoxicity of cisplatin and 5-fluorouracil on CD44(+) cancer stem cells.
    Najafzadeh N; Mazani M; Abbasi A; Farassati F; Amani M
    Biomed Pharmacother; 2015 Aug; 74():243-51. PubMed ID: 26349992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relationship between dihydropyrimidine dehydrogenase(DPD) activity and toxicity of 5-FU-based adjuvant chemotherapy in colorectal cancer patients].
    Zhou ZW; Wang GQ; Wan DS; Pan ZZ; Li S; Chen G; Liao H
    Ai Zheng; 2004 Nov; 23(11 Suppl):1512-6. PubMed ID: 15566669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case of gastric cancer with liver metastasis responding to low-dose CDDP/5-FU combination chemotherapy].
    Iwatani Y; Ohno M; Kamigaki T; Nakamura T; Suzuki Y; Iwasaki T; Sinmaru H; Hirata K; Kuroda Y
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):277-80. PubMed ID: 10700900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination chemotherapy of 5-fluorouracil and low-dose cisplatin in advanced and recurrent gastric cancer: a multicenter retrospective study in Nagasaki, Japan.
    Enjoji A;
    Anticancer Res; 2002; 22(2B):1135-9. PubMed ID: 12168913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Optimal administration in combination chemotherapy with 5-fluorouracil and cisplatin for gastric cancer].
    Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1763-9. PubMed ID: 8937486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer].
    Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N; Kitahara S; Tamura E; Tanabe T; Nakanoboh M; Kawada M; Shirasaka T
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.
    Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K
    J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
    Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
    Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial.
    Al-Batran SE; Kerber A; Atmaca A; Dechow C; Reitsamer E; Schmidt S; Kolassa Y; Neumann A; Weidmann E; Hartmann JT; Jäger E
    Onkologie; 2007 Feb; 30(1-2):29-34. PubMed ID: 17264523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of advanced gastric cancer that responded to docetaxel with low-dose 5-FU and cisplatin combination chemotherapy after becoming chemoresistant to M-FLP].
    Funakoshi K; Tasaki A; Inayoshi J; Arai F; Motoyama H; Akiyama N; Kato T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1967-71. PubMed ID: 14650969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of advanced gastric cancer with virchow's metastasis responding remarkably to combination chemotherapy of low-dose CDDP and 5-FU].
    Kajihara K; Ishikawa H; Akama F; Ninomiya H; Shigeta K; Sano I; Nakamura Y; Iwasaki K
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):585-8. PubMed ID: 9530367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M; Kanke M; Tomita T
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effects of 5-Fluorouracil and heparin-based portal infusion chemotherapy combined with mitomycin C and cisplatin after curative resection of pancreatic cancer.
    Aiura K; Takahashi S; Matsui J; Ueda M; Kitagawa Y
    Pancreatology; 2010; 10(2-3):250-8. PubMed ID: 20484963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
    Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
    Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.